Search Browse Earnings

Virpax Pharmaceuticals, Inc.

OTC:VRPX

Pharmaceutical Preparations·BERWYN, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CFO

Shah Vinay

Revenue

—

Adj. EBITDA

—

Net Income

-$15.2M

FY 2024

EPS (Diluted)

-$12.97

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$9.1M

FY 2024

Total Debt

—

Net Cash

$9.1M

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—